ESC 2021: Late-breaking Science Video Collection
Published: 02 September 2021
-
Views:
6179 -
Likes:
7
-
Views:
6179 -
Likes:
7
-
Up Next
-
8m 40sPart 3 | Session 3 TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI
-
5m 21sPart 3 | Session 4 The LAAOS III Study: Surgical AFIB Ablation Evaluation
-
9mPart 3 | Session 5 TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type
-
5m 43sPart 3 | Session 6 STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS
-
5m 41sPart 3 | Session 7 SPLENDOR: Metabolic Surgery and Risk of MACE in NASH
-
5m 11s
-
6m 9sPart 3 | Session 9 VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes
-
5m 50sPart 3 | Session 10 Micra CED: 2-Year Outcomes with Leadless Pacing
-
10m 53sPart 3 | Session 11 RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes
-
25m 18sPart 1 | Session 1 View from the Thoraxcenter – What's Hot at ESC 2021 Nicolas M Van Mieghem, Joost Daemen
-
36m 1sPart 1 | Session 2 View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up Joost Daemen, Nicolas M Van Mieghem
-
19m 47sPart 2 | Session 1 ESC 2021 Discussion: The EMPEROR-Preserved Trial Harriette Van Spall, Stefan Anker
-
15m 2sPart 2 | Session 2 ESC 2021 Discussion: The FIGARO-DKD Trial Bertram Pitt, Harriette Van Spall
-
20m 8sPart 2 | Session 3 ESC 2021 Discussion: The EMPEROR-Pooled Study Milton Packer, Harriette Van Spall
-
6m 33sPart 3 | Session 1 ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI George D Dangas
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data.
For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
View from the Thoraxcenter
Part 2
Late-breaker Discussion Series
Part 3
Expert Interviews
Part 4
Masterclass with Dr Harriette Van Spall & Dr Birgit Vogel
Faculty Biographies
Adrian P Banning
Consultant Cardiologist
Prof Adrian Banning is a Consultant Cardiologist, specialising in percutaneous coronary intervention. He works as a Consultant in interventional and general cardiology and is one of the founder members of the Oxford Private Heart and Lung Centre at Nuffield Health Oxford at The Manor Hospital.
He is recognised as one of the UK’s top interventional cardiologists and until recently he was President of the British Cardiac Intervention Society. He performs more than 250 coronary intervention procedures every year and he is an expert in TAVI –implantation of a new aortic valve through a keyhole incision and performs >150 of these TAVI procedures each year.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.